Beauty Farm Medical and Health Industry Inc. (FRA:XC5)
Germany
· Delayed Price · Currency is EUR 2.260
-0.140 (-5.83%)
At close: Mar 9, 2026
FRA:XC5 Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Market Capitalization | 626 | 522 | 303 | - | - | - | Upgrade
|
| Market Cap Growth | 21.23% | 72.50% | - | - | - | - | Upgrade
|
| Enterprise Value | 484 | 399 | 188 | - | - | - | Upgrade
|
| Last Close Price | 2.40 | 1.97 | 1.39 | - | - | - | Upgrade
|
| PE Ratio | 19.59 | 17.26 | 11.00 | - | - | - | Upgrade
|
| PS Ratio | 1.82 | 1.53 | 1.11 | - | - | - | Upgrade
|
| PB Ratio | 5.67 | 4.04 | 2.84 | - | - | - | Upgrade
|
| P/TBV Ratio | - | - | 4.70 | - | - | - | Upgrade
|
| P/FCF Ratio | 5.71 | 5.78 | 5.09 | - | - | - | Upgrade
|
| P/OCF Ratio | 5.35 | 4.95 | 3.79 | - | - | - | Upgrade
|
| EV/Sales Ratio | 1.39 | 1.17 | 0.69 | - | - | - | Upgrade
|
| EV/EBITDA Ratio | 5.15 | 6.69 | 3.82 | - | - | - | Upgrade
|
| EV/EBIT Ratio | 10.86 | 9.74 | 5.48 | - | - | - | Upgrade
|
| EV/FCF Ratio | 4.42 | 4.41 | 3.16 | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.84 | 0.75 | 0.68 | 2.59 | 1.96 | 3.67 | Upgrade
|
| Debt / EBITDA Ratio | 1.00 | 1.06 | 0.94 | 1.22 | 0.97 | 1.12 | Upgrade
|
| Debt / FCF Ratio | 0.85 | 1.07 | 1.21 | 2.18 | 0.96 | 0.84 | Upgrade
|
| Net Debt / Equity Ratio | -1.31 | -1.13 | -1.21 | -1.90 | -2.16 | -2.03 | Upgrade
|
| Net Debt / EBITDA Ratio | -2.32 | -2.44 | -2.62 | -1.59 | -1.59 | -0.95 | Upgrade
|
| Net Debt / FCF Ratio | -1.32 | -1.61 | -2.17 | -1.60 | -1.06 | -0.47 | Upgrade
|
| Asset Turnover | 0.75 | 0.68 | 0.74 | 0.66 | 0.78 | 0.77 | Upgrade
|
| Inventory Turnover | 6.80 | 6.30 | 5.61 | 5.75 | 8.30 | 7.44 | Upgrade
|
| Quick Ratio | 0.75 | 0.70 | 0.81 | 0.52 | 0.61 | 0.54 | Upgrade
|
| Current Ratio | 0.84 | 0.80 | 0.94 | 0.65 | 0.71 | 0.62 | Upgrade
|
| Return on Equity (ROE) | 33.02% | 27.91% | 44.37% | 47.48% | 103.33% | 157.33% | Upgrade
|
| Return on Assets (ROA) | 5.98% | 5.10% | 5.80% | 3.41% | 7.03% | 6.50% | Upgrade
|
| Return on Invested Capital (ROIC) | - | - | - | - | - | 2633.64% | Upgrade
|
| Return on Capital Employed (ROCE) | 23.90% | 20.10% | 21.50% | 23.20% | 41.30% | 39.60% | Upgrade
|
| Earnings Yield | 5.10% | 5.79% | 9.09% | - | - | - | Upgrade
|
| FCF Yield | 17.52% | 17.30% | 19.66% | - | - | - | Upgrade
|
| Dividend Yield | 2.38% | 3.23% | 3.91% | - | - | - | Upgrade
|
| Payout Ratio | 41.35% | 49.24% | 40.34% | 198.10% | 41.95% | 70.71% | Upgrade
|
| Buyback Yield / Dilution | 0.15% | 0.14% | -14.99% | -0.24% | - | - | Upgrade
|
| Total Shareholder Return | 2.52% | 3.38% | -11.08% | -0.24% | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.